Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial.

Williams, C. orcid.org/0000-0002-1574-653X, Seligmann, J.F. orcid.org/0000-0003-4379-6005, Guetter, C. et al. (13 more authors) (2021) Artificial intelligence-assisted immunohistochemical (IHC) evaluation of tumor amphiregulin (AREG) and epiregulin (EREG) expression as a combined predictive biomarker for panitumumab (Pan) therapy benefit in RAS wild-type (wt) metastatic colorectal cancer (mCRC): Analysis within the phase III PICCOLO trial. In: Journal of Clinical Oncology. 2021 Gastrointestinal Cancers Symposium, 15-17 Jan 2021, Online. American Society of Clinical Oncology , p. 111.

Metadata

Item Type:	Proceedings Paper
Authors/Creators:	Williams, C. https://orcid.org/0000-0002-1574-653X Seligmann, J.F. https://orcid.org/0000-0003-4379-6005 Guetter, C. Zhang, L. Yan, D. Muranyi, A. Bai, I. Singh, S. Elliott, F. Shires, M. https://orcid.org/0000-0003-0904-6200 Richman, S. https://orcid.org/0000-0003-3993-5041 West, N. https://orcid.org/0000-0002-0346-6709 Barrett, J. Seymour, M.T. https://orcid.org/0000-0002-2441-9629 Quirke, P. https://orcid.org/0000-0002-3597-5444 Shanmugam, K.
Dates:	Published: 20 January 2021 Published (online): 22 January 2021
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Oncology The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Pathology and Data Analytics
Funding Information:	Funder Grant number Innovate UK fka Technology Strategy Board (TSB) TS/S012702/1 104687 Cancer Research UK Supplier No: 138573 C6003/A6407 Cancer Research UK Supplier No: 138573 C6003/A7367 Bousfield Holdings Ltd C6003/A6407 Amgen Limited *USE 819922* NOT GIVEN Cancer Research UK Supplier No: 138573 C6003/A15546 Leeds Teaching Hospitals Charitable Foundation 4616 Cancer Research UK Supplier No: 138573 C7852/A19772 Leeds Hospitals Charity 1T01-A321
Depositing User:	Symplectic Publications
Date Deposited:	11 Dec 2023 10:02
Last Modified:	11 Dec 2023 10:02
Status:	Published
Publisher:	American Society of Clinical Oncology
Identification Number:	10.1200/jco.2021.39.3_suppl.111
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:206381

CORE (COnnecting REpositories)

Metadata

Download not available

Export

Statistics